Condition
Decompensated Cirrhosis and Ascites
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (3)
Trial Status
Recruiting2
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06764966Phase 2Recruiting
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
NCT05056220Phase 3RecruitingPrimary
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
NCT06121479Phase 3Enrolling By InvitationPrimary
Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients
NCT03451292Phase 3CompletedPrimary
Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites
Showing all 4 trials